These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

491 related items for PubMed ID: 7691959

  • 1. Interactions of soluble CD59 with the terminal complement complexes. CD59 and C9 compete for a nascent epitope on C8.
    Lehto T, Meri S.
    J Immunol; 1993 Nov 01; 151(9):4941-9. PubMed ID: 7691959
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9.
    Rollins SA, Zhao J, Ninomiya H, Sims PJ.
    J Immunol; 1991 Apr 01; 146(7):2345-51. PubMed ID: 1706395
    [Abstract] [Full Text] [Related]

  • 3. Binding of human and rat CD59 to the terminal complement complexes.
    Lehto T, Morgan BP, Meri S.
    Immunology; 1997 Jan 01; 90(1):121-8. PubMed ID: 9038722
    [Abstract] [Full Text] [Related]

  • 4. A synthetic peptide from complement protein C9 binds to CD59 and enhances lysis of human erythrocytes by C5b-9.
    Tomlinson S, Whitlow MB, Nussenzweig V.
    J Immunol; 1994 Feb 15; 152(4):1927-34. PubMed ID: 7509832
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of C9 polymerization within the SC5b-9 complex of complement by S-protein.
    Podack ER, Preissner KT, Müller-Eberhard HJ.
    Acta Pathol Microbiol Immunol Scand Suppl; 1984 Feb 15; 284():89-96. PubMed ID: 6587746
    [Abstract] [Full Text] [Related]

  • 6. The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9.
    Rollins SA, Sims PJ.
    J Immunol; 1990 May 01; 144(9):3478-83. PubMed ID: 1691760
    [Abstract] [Full Text] [Related]

  • 7. Crystal structure of CD59: implications for molecular recognition of the complement proteins C8 and C9 in the membrane-attack complex.
    Huang Y, Fedarovich A, Tomlinson S, Davies C.
    Acta Crystallogr D Biol Crystallogr; 2007 Jun 01; 63(Pt 6):714-21. PubMed ID: 17505110
    [Abstract] [Full Text] [Related]

  • 8. Several epitopes on native human complement C9 are involved in interaction with the C5b-8 complex and other C9 molecules.
    Kontermann R, Deppisch R, Rauterberg EW.
    Eur J Immunol; 1990 Mar 01; 20(3):623-8. PubMed ID: 1690659
    [Abstract] [Full Text] [Related]

  • 9. On the cause and nature of C9-related heterogeneity of terminal complement complexes generated on target erythrocytes through the action of whole serum.
    Bhakdi S, Tranum-Jensen J.
    J Immunol; 1984 Sep 01; 133(3):1453-63. PubMed ID: 6747293
    [Abstract] [Full Text] [Related]

  • 10. Loss of expression of protectin (CD59) is associated with complement membrane attack complex deposition in myocardial infarction.
    Väkevä A, Laurila P, Meri S.
    Lab Invest; 1992 Nov 01; 67(5):608-16. PubMed ID: 1279272
    [Abstract] [Full Text] [Related]

  • 11. The human complement regulatory protein CD59 binds to the alpha-chain of C8 and to the "b"domain of C9.
    Ninomiya H, Sims PJ.
    J Biol Chem; 1992 Jul 05; 267(19):13675-80. PubMed ID: 1377690
    [Abstract] [Full Text] [Related]

  • 12. Transmembrane channel-formation by five complement proteins.
    Müller-Eberhard HJ.
    Biochem Soc Symp; 1985 Jul 05; 50():235-46. PubMed ID: 2428370
    [Abstract] [Full Text] [Related]

  • 13. Clusterin, the human apolipoprotein and complement inhibitor, binds to complement C7, C8 beta, and the b domain of C9.
    Tschopp J, Chonn A, Hertig S, French LE.
    J Immunol; 1993 Aug 15; 151(4):2159-65. PubMed ID: 8345200
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Incorporation of human complement C8 into the membrane attack complex is mediated by a binding site located within the C8beta MACPF domain.
    Brannen CL, Sodetz JM.
    Mol Immunol; 2007 Feb 15; 44(5):960-5. PubMed ID: 16624411
    [Abstract] [Full Text] [Related]

  • 16. C5b-9 assembly: average binding of one C9 molecule to C5b-8 without poly-C9 formation generates a stable transmembrane pore.
    Bhakdi S, Tranum-Jensen J.
    J Immunol; 1986 Apr 15; 136(8):2999-3005. PubMed ID: 3958488
    [Abstract] [Full Text] [Related]

  • 17. Characterization of rabbit complement component C8. Functional evidence for the species-selective recognition of C8 alpha by homologous restriction factor (CD59).
    White RV, Kaufman KM, Letson CS, Platteborze PL, Sodetz JM.
    J Immunol; 1994 Mar 01; 152(5):2501-8. PubMed ID: 7510745
    [Abstract] [Full Text] [Related]

  • 18. Regulation of the membrane attack complex of complement. Evidence that C8 gamma is not the target of homologous restriction factors.
    Davé SJ, Sodetz JM.
    J Immunol; 1990 Apr 15; 144(8):3087-90. PubMed ID: 2324496
    [Abstract] [Full Text] [Related]

  • 19. Functional studies of the MACPF domain of human complement protein C8alpha reveal sites for simultaneous binding of C8beta, C8gamma, and C9.
    Slade DJ, Chiswell B, Sodetz JM.
    Biochemistry; 2006 Apr 25; 45(16):5290-6. PubMed ID: 16618117
    [Abstract] [Full Text] [Related]

  • 20. Mapping of the complement C9 binding domain in paramyosin of the blood fluke Schistosoma mansoni.
    Deng J, Gold D, LoVerde PT, Fishelson Z.
    Int J Parasitol; 2007 Jan 25; 37(1):67-75. PubMed ID: 17123534
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.